|
Home /
Janssen-Cilag / Janssen-Cilag
news
Janssen-Cilag - pharmaceutical news
 Janssen-Cilag news
STELARA(tm) shows greater efficacy than etanercept for treatment of moderate to severe plaque psoriasis Results from first Phase III comparator study of biologic agents in psoriasis published today in New England Journal of Medicine Metabolic effects significantly lower with INVEGA® compared to oral olanzapine in people with schizophrenia New data from a 6-month open label randomised controlled trial show INVEGA® (paliperidone ER) is associated with significantly less metabolic effects compared to oral olanzapine in people with schizophrenia, while demonstrating comparable efficacy. Priligy first oral prescription medication approved for PE Priligy™ (dapoxetine) receives first regulatory approvals for the treatment of premature ejaculation (PE) in Finland and Sweden New Antibiotic To Treat Serious Infections European Authority Recommends Approval of DORIBAX for treatment of nosocomial pneumonia, complicated intra-abdominal and complicated urinary tract infections Invega® receives marketing authorisation in European Union for threatment of schizophrenia. Invega® receives marketing authorisation in European Union for threatment of schizophrenia. First Oral Prolonged-Release Medication to Treat Schizophrenia. Janssen-Cilag International NV submits marketing authorization application in Europe for new antiobiotic. Janssen-Cilag International NV submits marketing authorization application in Europe for new antiobiotic ceftobiprole, an investigational antibiotic for the treatment of complicated skin and soft tissue infections (cSSTI) including diabetic foot infections. INVEGA® receives positive opinion from European Committee for Human Medicinal Products (CHMP) INVEGA® receives positive opinion from European Committee for Human Medicinal Products for Treatment of Schizophrenia. INVEGA™ approved by FDA as new treatment for schizophrenia The U.S. Food and Drug Administration (FDA) has approved INVEGA™ (paliperidone) Extended-Release Tablets, a new atypical antipsychotic, for the treatment of schizophrenia. Mother & daughters' journey through madness Out of the Shadow, Susan Smiley's award-winning documentary film, is now available to view on our European Psychiatry 24x7 website www.psychiatry24X7.com. European Headache Alliance launches at European Parliament with 1st ever Migraine Day of Action Migraine patients unite to end intolerance and prejudice against people living with migraine |
